TITLE

Progressive multifocal leukoencephalopathy in autoimmune disorders

AUTHOR(S)
Focosi, D.; Maggi, F.; Ceccherini-Nelli, L.; Marchi, S.; Petrine, M.
PUB. DATE
April 2009
SOURCE
Gut;Apr2009, Vol. 58 Issue 4, p605
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the misconceptions on the article by Verbeek on JC viral loads as a predictor of progressive multifocal leukoencephalopathy (PML) in patients with Crohn's disease. It cites the author's statement saying that PML has been associated with immunosuppression as a consequence of organ transplantation and hematological malignancies. It adds that the author also interpret JC viruria in a seronegative gastrointestinal control as evidence of primo-infection.
ACCESSION #
45646924

 

Related Articles

  • Pre-Existing T- and B-Cell Defects in One Progressive Multifocal Leukoencephalopathy Patient. Sottini, Alessandra; Capra, Ruggero; Zanotti, Cinzia; Chiarini, Marco; Serana, Federico; Ricotta, Doris; Caimi, Luigi; Imberti, Luisa // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Progressive multifocal leukoencephalopathy (PML) usually occurs in patients with severe immunosuppression, hematological malignancies, chronic inflammatory conditions or receiving organ transplant. Recently, PML has also been observed in patients treated with monoclonal antibodies. By taking...

  • Pre-Existing T- and B-Cell Defects in One Progressive Multifocal Leukoencephalopathy Patient. Sottini, Alessandra; Capra, Ruggero; Zanotti, Cinzia; Chiarini, Marco; Serana, Federico; Ricotta, Doris; Caimi, Luigi; Imberti, Luisa // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Progressive multifocal leukoencephalopathy (PML) usually occurs in patients with severe immunosuppression, hematological malignancies, chronic inflammatory conditions or receiving organ transplant. Recently, PML has also been observed in patients treated with monoclonal antibodies. By taking...

  • Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation. Capobianco, Marco; Motuzova, Y.; Frau, J.; Cocco, E.; Mamusa, E.; Marrosu, M.; Bertolotto, A. // Neurological Sciences;Aug2012, Vol. 33 Issue 4, p863 

    High-dose cyclophosphamide followed by autologous haematopoietic stem cell transplantation (HDC-AHSCT) is a treatment option for aggressive and refractory multiple sclerosis (MS). Natalizumab is a monoclonal antibody approved for relapsing-remitting (RR) MS unresponsive to immunomodulating...

  • Immunosuppressants/methotrexate.  // Reactions Weekly;8/18/2012, Issue 1415, p25 

    The article describes the case of an elderly woman who developed progressive multifocal leukoencephalopathy after taking immunosuppressants and methotrexate.

  • Long-term results of renal transplantation in children. Potter, Donald E.; Najarian, John; Belzer, Folkert; Holliday, Malcolm A.; Horns, Gloria; Salvatierra Jr., Oscar // Kidney International;Oct1991, Vol. 40 Issue 4, p752 

    The results of renal transplantation in 37 children, 3 through 16 years of age, who received transplants prior to June, 1970 in our center, were examined. Twenty-three received kidneys from living-related donors and 14 received kidneys from cadaver donors. Patient survival rates were 78% at 10...

  • Small Molecule Immunosuppressive Agents in Experimental and Clinical Transplantation. Ma, A.; Chen, H. // Current Drug Targets - Cardiovascular & Haematological Disorders;Dec2002, Vol. 2 Issue 2, p57 

    Immunosuppression is currently the major approach used for the prevention and management of transplant rejection. In this overview, preclinical and clinical studies of the small molecule immunosuppressive agents are reviewed from the discovery of cyclosporine. More recently it was demonstrated...

  • Progressive Multifocal Leukoencephalopathy and Newer Biological Agents. Berger, J. R. // Drug Safety;2010, Vol. 33 Issue 11, p969 

    Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease of the brain due to a polyoma virus, JC virus. Despite the ubiquity of this virus, PML is rare and almost always seen in association with an underlying immunosuppressive condition. In the last 30 years, AIDS has...

  • Balancing Efficacy and Toxicity in Kidney-Transplant Immunosuppression. Leichtman, Alan B. // New England Journal of Medicine;12/20/2007, Vol. 357 Issue 25, p2625 

    The author reflects on the importance of balancing efficacy and toxicity in kidney transplant immunosuppression, and on research conducted on the issue by a researcher named H. Ekberg. He suggests that the data presented by the researchers are compelling and reproducible. He argues that the...

  • Corticosteroid avoidance in pediatric renal transplantation. Vidhun, Jayakumar; Sarwal, Minnie // Pediatric Nephrology;Mar2005, Vol. 20 Issue 3, p418 

    Corticosteroids have played a central role in the evolution of renal transplant as the modality of choice for renal replacement in end stage kidney disease. Their use is associated with significant, dose related morbidity including osseous, cardiovascular, metabolic complications, body...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics